Evommune, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
EVMN$7.84+2.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
(in thousands, except share and per share amounts)
| March 31, · December 31, | ||||
|---|---|---|---|---|
| 2026 · 2025 | ||||
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | $ | 48,318 | $ | 44,063 |
| Short-term investments | 163,146 | 105,137 | ||
| Prepaid expenses and other current assets | 4,391 | 4,278 | ||
| Total current assets | 215,855 | 153,478 | ||
| Operating lease right-of-use assets, net | 7,930 | 1,469 | ||
| Property and equipment, net | 1,640 | 994 | ||
| Long-term investments | 95,548 | 67,489 | ||
| Restricted cash | 1,409 | 1,415 | ||
| Other non-current assets | 73 | 101 | ||
| Total assets | $ | 322,455 | $ | 224,946 |
| Liabilities and Stockholders’ Equity | ||||
| Current liabilities: | ||||
| Accounts payable | $ | 4,045 | $ | 7,756 |
| Accrued liabilities | 4,734 | 9,547 | ||
| Operating lease liability, current portion | 1,253 | 242 | ||
| Other current liabilities | 571 | 364 | ||
| Total current liabilities | 10,603 | 17,909 | ||
| Operating lease liability, non-current portion | 6,768 | 1,290 | ||
| Financing lease liability | 529 | 181 | ||
| Total liabilities | 17,900 | 19,380 | ||
| Stockholders’ equity: | ||||
| Common stock, par value $0.0001 — 500,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; 36,018,372 and 31,524,093 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 4 | 3 | ||
| Additional paid-in capital | 547,314 | 426,652 | ||
| Accumulated deficit | (242,763) | (221,089) | ||
| Total stockholders’ equity | 304,555 | 205,566 | ||
| Total liabilities and stockholders’ equity | $ | 322,455 | $ | 224,946 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.